Comprehensive Functional Assessments for NOCAD
- Conditions
- Coronary Artery DiseaseMyocardial IschemiaCoronary Microvascular Dysfunction
- Interventions
- Device: coronary physiological indices
- Registration Number
- NCT06175572
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Brief Summary
To validate and investigate the efficacy of comprehensive functional assessments for the diagnostic and prognostic value in NOCAD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1000
- visual evaluation of epicardial coronary artery diameter stenosis (DS%) ≤ 50%;
- CZT-SPECT was successfully conducted within three days of CAG
- had flow-limiting epicardial stenosis (DS% >50%) or angiography-derived FFR (Angio-FFR) ≤ 0.8;
- severe valvular heart disease;
- chronic heart failure and/or left ventricular ejection fraction (LVEF) of < 50%;
- cardiomyopathy and myocarditis;
- severe renal or hepatic insufficiency;
- failure in detecting SPECT;
- failure in computing Angio-IMR, and -FFR.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CSF cohort coronary physiological indices Coronary slow-flow patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT). ANOCA cohort coronary physiological indices Angina with nonobstructive coronary artery patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT). INOCA cohort coronary physiological indices Ischemia with nonobstructive coronary artery patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT). NCF cohort coronary physiological indices Normanl coronary-flow patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT).
- Primary Outcome Measures
Name Time Method Major adverse cardiac events (MACE) 5 years The composite of coronary heart disease death, nonfatal myocardial infarction, hospitalization for unstable angina, or fatal or nonfatal ischemic stroke.
- Secondary Outcome Measures
Name Time Method Individual components of MACE 5 years Cumulative incidence of the individual components of MACE
the change in Seattle Angina Questionnaire (SAQ) summary score 5 years The SAQ comprises 5 components namely physical limitation, angina stability, angina frequency, treatment satisfaction, and quality of life; these are then incorporated into the summary score. The higher the score, the better the patient's quality of life and physical function.
the change in Seattle Angina Questionnaire (SAQ) score of indivadual scale 5 years The SAQ comprises 5 components namely physical limitation, angina stability, angina frequency, treatment satisfaction, and quality of life. The higher the score, the better the patient's quality of life or physical function.
Trial Locations
- Locations (1)
Zhongshan hospital, Fudan university
🇨🇳Shanghai, China